Role of Obesity in the Pathogenesis and Progression of Barrett's Esophagus.

Gastroenterol Clin North Am

Barrett's Esophagus Unit, Division of Gastroenterology and Hepatology, Mayo Clinic, 200 1st Street South West, Rochester, MN 55905, USA. Electronic address:

Published: June 2015

Central obesity is involved in the pathogenesis and progression of Barrett's esophagus to esophageal adenocarcinoma. Involved are likely both mechanical and nonmechanical effects. Mechanical effects of increased abdominal fat cause disruption of the gastroesophageal reflux barrier leading to increased reflux events. Nonmechanical effects may be mediated by inflammation, via classically activated macrophages, pro-inflammatory cytokines, and adipokines such as Leptin, all of which likely potentiate reflux-mediated inflammation. Insulin resistance, associated with central obesity, is also associated with both Barrett's pathogenesis and progression to adenocarcinoma. Molecular pathways activated in obesity, inflammation and insulin resistance overlap with those involved in Barrett's pathogenesis and progression.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.gtc.2015.03.001DOI Listing

Publication Analysis

Top Keywords

pathogenesis progression
16
progression barrett's
8
barrett's esophagus
8
central obesity
8
nonmechanical effects
8
inflammation insulin
8
insulin resistance
8
barrett's pathogenesis
8
role obesity
4
pathogenesis
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!